Diagnosis of human papillomavirus in uterine cervix of women undergoin annual cytologic checkup;Diagnostico del virus papiloma humano en cuello uterino de mujeres que acuden a su consulta anual citológica

Salus

Volumn 8, Issue 1, 2004, Pages 26-31

  Reigosa, Aldo ^a,b   Alvarez, Maritza ^a,c   De Vasconcelo, Micaela ^a   Cristina, Rosa ^a   Salas, Wendy ^a   Rebolledo, Vilma ^a,b   Voldman, Alegría ^a,d  

^a UNIVERSIDAD DE CARABOBO   (Venezuela)

^b Hospital Miguel Perez Carreno   (Venezuela)

^c Laboratorio Genomik CA Maracay   (Venezuela)

^d Ctro Med Preventiva Munic B C   (Venezuela)

Author keywords

HPV; PCR; Uterine cervix cancer

Indexed keywords

ADULT; AGE; ARTICLE; CYTOLOGY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIPARA; POLYMERASE CHAIN REACTION; SEXUAL BEHAVIOR; SMOKING; UTERINE CERVIX; VIRUS DETECTION; VIRUS STRAIN; WART VIRUS;

EID: 3142550729     PISSN: 13167138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodríguez AC, Helgesen K, Alfaro M, Hutchinson M, Balmaceda I, Greenberg M, Schiffman M. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer. 2001; 84:1219-1226.
2. Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Walcholder S, Alfaro M, Hutchinson M, Morales J, Greenberg MD, Lorincz AT. HPV DNA testing in cervical cancer screening: results from women in high-risk province of Costa Rica. JAMA. 2000; 283:87-93.
3. Garcia M, Reeves W, Brinton L. Human papillomavirus infection and cervical cancer in Latinoamerica. N Engl J Med. 1993; 320:1437-1441.
4. Chichareon S, Herrero R, Muñoz N, Bosch FX, Jacobs MV, Deacon J, Santamaria M, Chongsuvivatwong V, Meijer CJ, Walboomers JM. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst. 1998; 90:50-57.
5. Koss LG. Cervical (Pap) smear. New directions. Cancer. 1993; 71(Suppl):1406-1412.
6. Zur Hausen H. Molecular pathogenesis of cancer of cervix and its causation by specific human papilomavirus types. Curr Top Microbiol Immunol. 1994; 186:131-156.
7. Tjound P, Hisaya F, Thomas W. Molecular biology of cancer and its precursors. Cancer Rev. 1995; 76:1902-1913.
8. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999; 189:12-19.
9. Alvarez M, Chiarello A, Espinal E, Reigosa A, Marrero M. Detección del virus papiloma humano (VPH) en grupo de pacientes con sospecha clínica y/o anatomopatológica de infección por VPH. Salus. 2000; 4:19-26.
10. Kurman, R. (2002). Blaustein's pathology of the female genital tract. Springer - Verlag, New York, 253-290.
11. Roman A, Fife KH. Human papillomavirus: Are we ready to type? Clin Microbiol Rev. 1989; 2: 166-190.
12. Miller AB. Failures of cervical cancer screening. Am J Public Health. 1995; 85:761-762.
13. De Villiers EM. Hybridization methods other than PCR: an update. In Munoz, N, Bosch F, Shah K, Meheus A. The epidemiology of Cervical Cancer and human papillomavirus. IARC Sci Publ. 1992, 119: 111-119.
14. Rozendaal L, Walboomers JM, van der Linden JC, Voorhorst FJ, Kenemans P, Helmerhorst TJ, van Ballegooijen M, Meijer CJ. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer. 1996; 68:766-769.
15. Meijer CJ, van den Brule AJ, Snidjders PJ, Helmerhorst T, Kenemans P, Walboomers JM. Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening. IARC Sci Publ. 1992; 119:271-281.
16. Jenkins D, Sherlaw-Johnson C, Gallivans S. Can papilloma virus testing be used to improve cervical cancer screening?. Int J Cancer. 1996; 65:768-773.
17. Resnick RM, Comelissen MT, Wright DK, Eichinger GH, Fox HS, terSchegget J, Manos MM. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst. 1990; 82:1477-1484.
18. Saiki RK, Gelfand DH. Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Ehrlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988; 239:487-491.
19. Kalantari M, Blennow E, Hagmar B, Johansson B. Physical state of HPV 16 and chromosomal mapping of the integrated form in cervical carcinomas. Diagn Mol Pathol. 2001; 10:46-54.
20. Hagmar B, Kalantari M, Skyldberg B, Moberger B, Johansson B, Walaas L, Warleby B. Human papillomavirus in cell samples from Stockholm Gynecologic Health Screening. Acta Cytol. 1995; 39:741-745.
21. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, DeRouen TA, Gallaway DA, Vernon D, Kiviat NB. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation with papillomavirus infection. N Engl J Med. 1992; 327:1272-1278.
22. Miller AB, Anderson G, Brisson J, Laidlaw J, Le Pitre N, Malcolmson P, Mirwaldt P, Stuart G, Sullivan W. Report of national workshop on screening for cancer of the cervix. CMAJ. 1991; 145:1301-1325.
23. Schneider A, Zahm DM, Kirchmary R, Schneider VL. Screening for cervical intraepithelial neoplasia grade 2/ 3: validity of cytologic study, cervicography, and human papillomavirus detection. Am J Obstet Gynecol. 1996; 174:1534-1541.
24. Snijders PJ, van den Brule AJ, Schrijnemakers HF, Snow G, Meijer CJ, Walboormers JM. The use of general primers in the polymerase chain reaction permits the detection of broad spectrum of human papillomavirus genotypes. J Gen Virol. 1990; 71:173-181.
25. Jacobs MV, Zielinski D, Meijer CJ, Voorhorst FJ, de Schipper FA, Runsink AP, Sneijders PJ, Walboomers JM. A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytological normal smears. Br J Cancer. 2000; 82:1421-1426.
26. Lorincz AT. Molecular methods for the detection of human papillomavirus infection. Obstet Gynecol Clin North Am. 1996; 23:707-730.
27. Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 1995; 87:1365-1371.
28. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, van der Linden HC, Voorhorst FJ, Kenemans P, Meijer CJ. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet. 1999; 354:20-25.
29. Galloway DA. Human papillomavirus vaccines: a warty problem. Infect Agents Dis. 1994; 3:187-193.
30. Tidy JA, Vousden KH, Farrell PJ. Relation between infection with a subtype of HPV 16 and cervical neoplasia. Lancet. 1989; 1:1225-1227.
31. Stone KM. Epidemiological aspects of genital HPV infection. Clin Obstet Gynecol. 1989; 32:112-116.
32. Sellors JW, Mahony JB, Kaczorowski J, Lytwyn A, Bangura H, Chong S, Lorincz A, Dalby DM, Janjusevic V, Keller JL. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ. 2000; 163:503-508.
33. Burk RD, Ho GY, Beardsley L, Lempa M, Peters M, Bierman R. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavims infection in young women. J Infect Dis. 1996; 174:679-689.
34. Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, Walboomers JM, Meijer CJ. Human papillomavirus-the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer. 1996; 65:601-606.
35. Moscicki AB, Palefsky J, Smith G, Siboshski S, Schoolnik G. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol. 1993; 82:578-585.
36. Prokopczyk B, Cox JE, Hoffmann D, Waggoner SE. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst. 1997; 89:868-873.
37. Johnson JD, Houchens DP, Kluwe WM, Craig DK, Fisher GL. Effects of mainstream and environmental tobacco smoke on the immune system in animals and humans: a review. Crit Rev Toxicol. 1990; 20:369-395.
38. Fife KH, Katz BP, Brizendine EJ, Brown DR. Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period. Am J Obstet Gynecol. 1999; 180:1110-1114.
39. Smith EM, Johnson SR, Jiang D, Zaleski S, Lynch CF, Brundage S, Anderson RD, Turek LP. The association between pregnancy and human papilloma virus prevalence. Cancer Detect Prev. 1991; 15:397-402.